Universal Reports 28% Drop in FY2026 Operating Income to $168.5 Million
UVV•Universal Corporation’s FY2026 revenue hit $2.92 billion, down 1%, while operating income fell 28% to $168.5 million and EPS was $1.30 after a $41.1 million goodwill impairment and $52 million tobacco inventory write-downs. Ingredients sales rose 3% to $348.1 million but operating income plunged 74% to $3.2 million.
1. Fiscal Year 2026 Results
Universal’s consolidated revenue was $2.9245 billion, down 1%, with operating income at $168.5 million, down 28%, and adjusted operating income at $211.3 million, down 13%. Diluted EPS was $1.30, compared with $3.78 prior year, after a $41.1 million goodwill impairment and $52.0 million write-downs.
2. Tobacco Operations
The tobacco segment generated $2.5764 billion in revenue, down 1%, on a 2% volume decline and price mix. Operating income fell 12% to $211.5 million, reflecting $43.4 million of inventory write-downs and oversupply in dark air-cured tobacco. Uncommitted inventory stood at 27%, expected to return to target.
3. Ingredients Operations
Ingredients revenue increased 3% to $348.1 million, driven by higher volumes, but operating income plunged 74% to $3.2 million. Results were weighed by $8.6 million of inventory write-downs at Shank’s and high fixed costs from facility expansion and market headwinds including tariffs.
4. Balance Sheet and Outlook
Total debt declined $168.7 million, while available liquidity remained about $1.3 billion. Management plans enhancements at the Shank’s plant to improve efficiency and expects uncommitted tobacco inventories to return to targeted levels during fiscal 2027, supporting sustainable value creation.
